Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

This study has been terminated.
(lack of recruitment)
Sponsor:
Information provided by (Responsible Party):
Philogen S.p.A.
ClinicalTrials.gov Identifier:
NCT01198522
First received: September 8, 2010
Last updated: November 19, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2014
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)